Active surveillance: a safe, low-cost prognostic test for prostate cancer.
Zietman
Anthony
A
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. azietman@partners.org
D018450:Disease Progression; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000191:economics / Q000473:pathology*